Johnson & Johnson, Procter & Gamble and other manufacturers on Monday said cough and cold drugs with the pain reliever acetaminophen should stay on the market despite concerns from U.S. regulators. . . .
Reuters - June 29, 2009
http://www.reuters.com/article/healthNews/idUSTRE55S62120090629?feedType=RSS&feedName=healthNews
